Statera Biopharma, Inc. Common Stock
STAB
STAB was delisted on the 11th of January, 2023.
17 hedge funds and large institutions have $456K invested in Statera Biopharma, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
42% more funds holding
Funds holding: 12 → 17 (+5)
18% less capital invested
Capital invested by funds: $556K → $456K (-$100K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$38.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$28.4K |
| 3 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$21K |
| 4 |
Renaissance Technologies
New York
|
+$4.99K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.92K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$276 |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $310K | +$4.99K | +3,700 | +1% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $54K | +$284 | +211 | +0.4% |
|
|
3
Citadel Advisors
Miami,
Florida
| $29K | +$38.3K | +28,435 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $21K | +$28.4K | +21,043 | New |
|
5
Geode Capital Management
Boston,
Massachusetts
| $17K | – | – | – |
|
|
BRWA
6
B. Riley Wealth Advisors
Boca Raton,
Florida
| $16K | +$21K | +15,588 | New |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | -$4 | -3 | -0.1% |
|
8
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $2K | – | – | – |
|
|
9
BlackRock
New York
| $1K | -$4.92K | -3,654 | -83% |
|
10
Victory Capital Management
San Antonio,
Texas
| $1K | +$1.16K | +859 | New |
|
|
11
UBS Group
Zurich,
Switzerland
| $1K | +$1.64K | +1,213 | New |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$276 | -205 | -37% |
|
|
IA
13
IFP Advisors
Tampa,
Florida
| – | +$876 | +650 | New |
|
STAB Hedge Fund Activity: Q3 2019 in Review
17 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q3 2019, worth a combined $456K — down 18% from $556K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new STAB positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $38.3K. The largest seller was BlackRock, cutting an estimated $4.92K.
- 17 institutional investors held Statera Biopharma, Inc. Common Stock (STAB) as of Q3 2019, up from 12 in Q2 2019.
- Funds reported $456K of Statera Biopharma, Inc. Common Stock stock for Q3 2019, down 18% quarter-over-quarter.
- 6 funds opened new Statera Biopharma, Inc. Common Stock positions in Q3 2019 and 1 closed out, a net change of +5 holders.
- The largest Statera Biopharma, Inc. Common Stock buyer in Q3 2019 was Citadel Advisors, an estimated $38.3K added.
- The largest Statera Biopharma, Inc. Common Stock seller in Q3 2019 was BlackRock, an estimated $4.92K sold.
Based on aggregated 13F filings for Q3 2019.